Ninety-four projects representing 19 countries were funded at the Phase I level. Projects focused on identifying anti-malarial compounds, communicating the positive impact of development aid, protecting crop plants, new approaches to optimize immunizations, and new solutions for global health priority areas. In addition, 15 projects received Phase II awards of up to $1 million each to support promising Phase I work.